Global multi-societies endorsement of the MAFLD definition Mohamed Alboraie; Tawesak Tanwandee; Xiaoyuan Xu; Dafina Nikolova; Enrique Carrera Estupiñan; Hasmik Ghazinyan; Sameer Alawadhi; Ponsiano Ocama; Gulnara Aghayeva; Alejandro Piscoya; Taghreed Farahat; Pramendra Prasad; Cosmas Rinaldi Adithya Lesmana; Shashank R Joshi; Said Al-Busafi; Vladimir Milivojevic; Violet Kayamba; Yeong Yeh Lee; Shahinul Alam; Chengwei Tang; Wei-Fen Xie; Moutaz Derbala; Yuemin Nan; Dennis Ndububa; Hongting Zheng; Jiajun Zhao; Nawal Alkhalidi; Yahya Ghanem; Phunchai Charatcharoenwitthaya; Mamun Mahtab; Nagwa N. Hegazy; Edford Sinkala; Cecil Kwaku Dovia; Moussa Ali Mahamat; Mortada El-Shabrawi; Dao Viet Hang; Shlomo Vinker; Bilal Hotayt; Mohammed Tahiri; Pavel Bogomolov; Nawal Afredj; Inass Shaltout; Reda Elwakil; Abd Elkhalek Hamed; Lubna Kamani; Maheeba Abdulla; Constant Assi; Oidov Baatarkhuu; Munira Al Tarrah; Yousef Ajlouni; Bounena Abidine; Christopher Muñoz; Mohammad Ali; Emad Salama; Abdelaziz Elamin; Iqbal Ahmad Memon; Aram Mirijanyan; Sajjad Jamil; Alexander V. Nersesov; Nseabasi Ekanem; Waseem Hamoudi; Bisi Bright; Teresa Casanovas; Ewaoche Itodo; Esther A Torres; Maja Karin; Enver Zerem; Svetlana Turcan; Audrius Dulskas; Iulianna Lupasco; Alina Jucov; Christian Tzeuton; Roger Sombie; Kateryna Lapshyna; Andrriy Dorofeyev; Yaw A Awuku; Hilal Ünalm¿¿ Duda; Rijimra Ande; Nehal El Koofy; Naglaa Kamal; Ziyan Pan; Angela Peltec; Liang Qiao; Andry Lalaina Rinà Rakotozafindrabe; Ahmed Salama; Reham Soliman; Badre Wafaa; Marinela Debu; Eileen A Micah; Gamal Shiha; Mohammed Eslam; Yasser Fouad;

MAFLD criteria are better than MASLD criteria at predicting the risk of chronic kidney disease Ziyan Pan; Moutaz Derbala; Khalid AlNaamani; Hasmik Ghazinian; Jian-Gao Fan; Mohammed Eslam;

MAFLD vs. MASLD: Consensus is unlike evidence! Enas Kamal; Alaa M Mostafa; Yasser Fouad;